Bakshi AK, Shrivastava V, Chattaraj A, Samuel K, Palani Selvam T, Sapra BK, Sinharoy P, Banerjee D, Sugilala G, Manohar S, Kaushik CP. Surface dose rate variations in planar and curved geometries of
106Ru/
106Rh plaque sources for ocular tumors.
Phys Med 2021;
89:200-209. [PMID:
34399207 DOI:
10.1016/j.ejmp.2021.08.001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 07/31/2021] [Accepted: 08/02/2021] [Indexed: 11/19/2022] Open
Abstract
PURPOSE
Investigation of surface dose rate variation with respect to the source configuration of 106Ru/106Rh eye plaque. To explore an alternate way to determine activity of brachytherapy plaques.
METHODS
The surface dose rates of 106Ru/106Rh plaque developed indigenously were measured by extrapolation chamber. To rule out possibility of any error in the activity distribution and quantity, same source was used in two different configurations namely planar and curved. EBT3 Gafchromic film was used for determination of uniformity in activity. Monte Carlo-based Codes EGSnrc and FLUKA were used to calculate dose rate in tissue, percentage depth dose and for determination of activity. Parameters and correction factors were estimated using simulations.
RESULTS
The measured reference absorbed dose rates for planar and curved 106Ru/106Rh eye plaques are found to be 589 ± 29 mGy/h and 560 ± 28 mGy/h, respectively. The difference in the reference absorbed dose rate of curved eye plaque is about ~5% as compared to planar configuration. The FLUKA-calculated dose values are almost independent of cavity length of the extrapolation chamber for both eye plaques. The FLUKA-based dose rates per μCi 106Ru/106Rh are about 17.28 ± 0.08 mGy/h and 16.48 ± 0.06 mGy/h, respectively for planar and curved eye plaques which match well with the measurements. The calculated activities for planar and curved eye plaques are 34.08 μCi and 33.98 μCi, respectively.
CONCLUSIONS
Surface dose rates for a prototype 106Ru/106Rh eye plaque with different configurations were estimated using simulations and measured experimentally. An alternate way to determine activity of beta-gamma brachytherapy plaque has been proposed.
Collapse